Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign

Prediction of Molecular Mutations in Diffuse Low-Grade Gliomas using MR Imaging Features

(2020) Zeina A. Shboul et al.   Scientific Reports

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study

(2020) Alba Corell et al.   BMC CANCER

Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype

(2019) S.H. Patel et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI

(2019) E. Aliotta et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Predicting the 1p/19q co-deletion status of presumed low grade glioma with an externally validated machine learning algorithm

(2019) Sebastian R van der Voort et al.   CLINICAL CANCER RESEARCH

Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign

(2019) Min Kyoung Lee et al.   EUROPEAN RADIOLOGY

MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization

(2019) Sohil H. Patel et al.   RADIOLOGY

Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation ofIDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas

(2018) Y.W. Park et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas

(2018) P. Chang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Machine Learning-Based Radiomics for Molecular Subtyping of Gliomas

(2018) Chia-Feng Lu et al.   CLINICAL CANCER RESEARCH

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis

(2018) S. C. Thust et al.   EUROPEAN RADIOLOGY

Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis

(2018) Chong Hyun Suh et al.   EUROPEAN RADIOLOGY

Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting

(2018) Anna Tietze et al.   JOURNAL OF NEUROSURGERY

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study

(2018) Martinus P G Broen et al.   NEURO-ONCOLOGY

Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas

(2018) C.-C. Wu et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas

(2018) Yuqi Han et al.   JOURNAL OF NEURO-ONCOLOGY

Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma

(2017) Arian Lasocki et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence

(2017) Zeynettin Akkus et al.   JOURNAL OF DIGITAL IMAGING

Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status

(2017) Rachel L. Delfanti et al.   JOURNAL OF NEURO-ONCOLOGY

Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomas

(2017) Kevin Leu et al.   JOURNAL OF NEURO-ONCOLOGY

MRI features predict survival and molecular markers in diffuse lower-grade gliomas

(2017) Hao Zhou et al.   NEURO-ONCOLOGY

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

(2017) Maarten M J Wijnenga et al.   NEURO-ONCOLOGY

Imaging Correlates of Adult Glioma Genotypes

(2017) Marion Smits et al.   RADIOLOGY

Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness

(2017) Michiru Nishita et al.   Scientific Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas

(2016) Taiichi Saito et al.   Brain Tumor Pathology

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

(2016) Michele Ceccarelli et al.   CELL

Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma

(2016) Changho Choi et al.   JOURNAL OF CLINICAL ONCOLOGY

Noninvasively detectingIsocitrate dehydrogenase 1gene status in astrocytoma by dynamic susceptibility contrast MRI

(2016) WenLi Tan et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters

(2016) Shunsuke Nakae et al.   JOURNAL OF NEURO-ONCOLOGY

Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion

(2016) Tomohiro Kawaguchi et al.   JOURNAL OF NEURO-ONCOLOGY

MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation ofIDH1Mutation Status

(2015) K. Yamashita et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling

(2015) Joseph M Foster et al.   BMC Medical Genomics

Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours

(2015) Ji Xiong et al.   EUROPEAN RADIOLOGY

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Radiological and Pathological Features Associated with IDH1-R132H Mutation Status and Early Mortality in Newly Diagnosed Anaplastic Astrocytic Tumours

(2015) Jason K. Wasserman et al.   PLoS One

Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging

(2014) Seunghyun Lee et al.   JOURNAL OF NEURO-ONCOLOGY

Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms

(2014) SONGTAO QI et al.   Oncology Letters

The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository

(2013) Kenneth Clark et al.   JOURNAL OF DIGITAL IMAGING

MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set

(2013) David A. Gutman et al.   RADIOLOGY

Multimodal MR Imaging (Diffusion, Perfusion, and Spectroscopy): Is It Possible to Distinguish Oligodendroglial Tumor Grade and 1p/19q Codeletion in the Pretherapeutic Diagnosis?

(2012) S. Fellah et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

(2010) Jörg Felsberg et al.   ACTA NEUROPATHOLOGICA

Molecular diagnostics of gliomas: state of the art

(2010) Markus J. Riemenschneider et al.   ACTA NEUROPATHOLOGICA

Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors

(2009) David Capper et al.   BRAIN PATHOLOGY